Related Experiment Videos
Furunculosis control using a paraimmunization stimulant (Baypamun) in rainbow trout
Veterinary Research
|January 1, 1996
Summary
Baypamun, an immune stimulant, significantly reduced furunculosis symptoms and infection levels in rainbow trout. While mortality reduction was not significant, it shows promise for managing fish diseases and carriers.
Area of Science:
- Aquatic animal health
- Immunology
- Fish disease management
Background:
- Furunculosis is a significant bacterial disease affecting farmed fish globally.
- Non-specific immune stimulants offer a potential strategy for disease control in aquaculture.
- Rainbow trout are susceptible to Aeromonas salmonicida, the causative agent of furunculosis.
Purpose of the Study:
- To evaluate the efficacy of Baypamun, a non-specific immune stimulant, in treating and controlling furunculosis in rainbow trout.
- To assess the impact of Baypamun on clinical signs, infection levels, and mortality rates.
- To explore the potential of immune stimulants as a future defense strategy in aquaculture.
Main Methods:
- Experimental infection of rainbow trout with Aeromonas salmonicida.
- Administration of Baypamun as a treatment.
- Monitoring of clinical symptoms, bacterial load in blood and organs, and mortality rates.
- Statistical analysis of the collected data.
Main Results:
- Baypamun treatment showed a statistically significant reduction in the cumulative incidence of furunculosis clinical symptoms.
- A significant decrease in the overall infection level was observed in Baypamun-treated fish.
- While mortality rates were reduced in the treated group, the difference was not statistically significant.
- Bacteria were detected in the blood and organs of treated fish, indicating subclinical infection.
Conclusions:
- Baypamun demonstrates potential in reducing furunculosis severity and infection levels in rainbow trout.
- Non-specific immune stimulants may serve as a valuable tool for managing fish diseases and controlling asymptomatic carriers.
- Further research is warranted to optimize the use of immune stimulants in aquaculture for enhanced disease resistance.